PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

Scientists have used AI to design a universal COVID vaccine and successfully tested it in humans. Two experts weigh in on how ...

The study was originally meant to be published in a CDC weekly report in March.

A COVID-19 vaccine study blocked by the CDC's acting director was published in a scientific journal. The study affirmed that ...

A 2026 study found compounds from a Brazilian tree kill COVID in the lab, matching the potency of remdesivir and molnupiravir ...

Despite vaccines and treatments, SARS-CoV-2—the virus that causes COVID-19—continues to pose a global health threat, driven by new variants and its ability to hijack human cells in ways that still ...

As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...

Infection with SARS-CoV-2 can lead to different acute clinical manifestations, ranging from mild respiratory disease to multi-organ dysfunction. It is becoming increasingly clear that infection with ...

SARS-CoV-2 has emerged as the 5th endemic coronavirus and immunological cross protection between coronaviruses will influence their infectivity and clinical impact. We determined adaptive immunity ...